Supernus Pharmaceuticals, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC SUPN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

703,625

Value ($000)

34,970

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	34,970	0.0%	703,625	12/31/2025
2025 Q3	11/10/2025	35,006	0.0%	732,489	9/30/2025
2025 Q2	8/12/2025	23,597	0.0%	748,641	6/30/2025
2025 Q1	9/15/2025	24,436	0.0%	746,149	3/31/2025
2024 Q4	2/6/2025	27,242	0.0%	753,363	12/31/2024
2024 Q3	11/12/2024	22,212	0.0%	712,395	9/30/2024
2024 Q2	8/12/2024	16,613	0.0%	621,041	6/30/2024
2024 Q1	5/9/2024	20,215	0.0%	592,646	3/31/2024
2023 Q4	2/6/2024	16,089	0.0%	555,930	12/31/2023
2023 Q3	11/8/2023	14,646	0.0%	531,246	9/30/2023
2023 Q2	8/10/2023	16,308	0.0%	542,508	6/30/2023
2023 Q1	5/12/2023	18,470	0.0%	509,806	3/31/2023
2022 Q4	2/13/2023	18,101	0.0%	507,451	12/31/2022
2022 Q3	11/14/2022	15,834	0.0%	467,774	9/30/2022
2022 Q2	8/15/2022	12,420	0.0%	429,451	6/30/2022
2022 Q1	5/13/2022	13,003	0.0%	402,290	3/31/2022
2021 Q4	2/11/2022	10,763	0.0%	369,092	12/31/2021
2021 Q3	11/16/2021	9,655	0.0%	362,005	9/30/2021
2021 Q2	8/16/2021	12,887	0.0%	418,540	6/30/2021
2021 Q1	5/17/2021	11,806	0.0%	450,929	3/31/2021
2020 Q4	2/16/2021	11,058	0.0%	439,497	12/31/2020
2020 Q3	11/13/2020	9,310	0.0%	446,714	9/30/2020
2020 Q2	8/20/2020	8,149	0.0%	343,082	6/30/2020
2020 Q1	5/15/2020	5,760	0.0%	320,144	3/31/2020
2019 Q4	2/7/2020	9,616	0.0%	405,368	12/31/2019
2014 Q2	7/30/2014	471	0.0%	43,000	6/30/2014
2014 Q1	4/29/2014	285	0.0%	31,800	3/31/2014
2013 Q4	2/14/2014	240	0.0%	31,800	12/31/2013